Ulcerative Colitis
Ulcerative colitis (UC) is a chronic inflammatory bowel disease that causes inflammation and ulcers in the lining of the colon, leading to symptoms such as abdominal pain, diarrhea, and rectal bleeding.
Guselkumab for Children with Ulcerative Colitis
We are studying whether guselkumab can effectively treat moderately to severely active ulcerative colitis in children. This trial will help us understand its safety and how well it works over time.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 2 and 17 years old?
- Do you weigh at least 10 kg?
- Do you have a diagnosis of ulcerative colitis (UC) confirmed by a doctor?
- Is your ulcerative colitis moderately to severely active?
- Do you have a stoma (an opening on your abdomen for waste)?
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
UZ Brussel
Kindergastro-enterologie, hepatologie en nutritie
Ganshoren, Belgium
UZ Leuven
Kindergastro-enterologie, hepatologie en nutritie
Heverlee, Belgium
Universitair Ziekenhuis Gent
Pediatric Gastroenterology, 3K12D
Ledeberg, Belgium
Sponsor: Janssen - Cilag International
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.